Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2015 Apr 11.

Published in final edited form as: J Dev Orig Health Dis. 2014 Dec 4;6(2):55–64. doi: 10.1017/S2040174414000580

Table 2.

Frequently studied disease/organ endpoints

1991 (n = 16)		2001 (n = 81)		2011 (n = 173)
Disease/endpoint	% of total^*	Disease/endpoint	% of total^*	Disease/endpoint	% of total^*
Brain/CNS	63	Brain/CNS	56	Brain/CNS	50
		Immune system	10	Breast	6
		Lung	10	Cancer	13
		Reproduction	10	Immune system	8
				Lung	11
				Obesity	7
				Reproduction	24

^*

Any endpoints accounting for <5% of the portfolio are not included.